BOJI MEDICAL TECHNOLOGY CO.,LTD. Financials Boji Medical Technology Co.,Ltd.
Equities
300404
CNE100001Y00
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.86 CNY | -0.51% |
|
+0.26% | -12.18% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,513 | 3,616 | 2,881 | 3,419 | 2,983 | - | - |
| Enterprise Value (EV) 1 | 2,513 | 3,616 | 2,881 | 3,419 | 2,983 | 2,983 | 2,983 |
| P/E ratio | 149 x | 87.1 x | 104 x | 136 x | 41.4 x | 29.7 x | 23.8 x |
| Yield | - | - | - | - | 0.19% | 0.25% | - |
| Capitalization / Revenue | - | - | - | 6.15 x | 3.53 x | 2.74 x | 2.37 x |
| EV / Revenue | - | - | - | 6.15 x | 3.53 x | 2.74 x | 2.37 x |
| EV / EBITDA | - | - | - | - | 25.3 x | 19.2 x | 16 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | 2.82 x | 2.56 x | 2.41 x |
| Nbr of stocks (in thousands) | 317,267 | 366,000 | 368,352 | 381,990 | 379,540 | - | - |
| Reference price 2 | 7.921 | 9.879 | 7.820 | 8.950 | 7.860 | 7.860 | 7.860 |
| Announcement Date | 4/26/21 | 4/25/22 | 4/25/23 | 4/24/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | 555.8 | 845.4 | 1,091 | 1,261 |
| EBITDA 1 | - | - | - | - | 118 | 155 | 187 |
| EBIT 1 | - | - | - | - | 103 | 139.5 | 155 |
| Operating Margin | - | - | - | - | 12.18% | 12.79% | 12.3% |
| Earnings before Tax (EBT) 1 | - | - | - | - | 103 | 139.5 | 155 |
| Net income 1 | 16.99 | 38.88 | 27.67 | 24.34 | 72.44 | 100.3 | 127.5 |
| Net margin | - | - | - | 4.38% | 8.57% | 9.19% | 10.11% |
| EPS 2 | 0.0533 | 0.1134 | 0.0753 | 0.0657 | 0.1900 | 0.2650 | 0.3300 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.0150 | 0.0200 | - |
| Announcement Date | 4/26/21 | 4/25/22 | 4/25/23 | 4/24/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | 7.12% | 8.98% | 10.3% |
| ROA (Net income/ Total Assets) | - | - | - | - | 5.45% | 6.4% | 5.8% |
| Assets 1 | - | - | - | - | 1,329 | 1,567 | 2,198 |
| Book Value Per Share 2 | - | - | - | - | 2.790 | 3.070 | 3.260 |
| Cash Flow per Share 2 | - | - | - | - | 0.1300 | 0.3500 | 0.1200 |
| Capex 1 | - | - | - | - | 46 | 47 | 62 |
| Capex / Sales | - | - | - | - | 5.44% | 4.31% | 4.92% |
| Announcement Date | 4/26/21 | 4/25/22 | 4/25/23 | 4/24/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.86
CNY
Average target price
11.74
CNY
Spread / Average Target
+49.36%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.18% | 412M | |
| +64.23% | 62.59B | |
| -2.31% | 41.18B | |
| +44.87% | 40.29B | |
| -8.29% | 27.9B | |
| +11.97% | 26.21B | |
| -21.16% | 19.09B | |
| +7.54% | 13.08B | |
| +27.17% | 12.05B | |
| +25.72% | 12.26B |
- Stock Market
- Equities
- 300404 Stock
- Financials Boji Medical Technology Co.,Ltd.
